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Abstract  
Urethral catheters are the most commonly deployed medical devices and used to manage a 
wide range of conditions in both hospital and community care settings. The use of long-term 
catheterisation, where the catheter remains in place for a period >28 days remains common, 
and the care of these patients is often undermined by the acquisition of infections and 
formation of biofilms on catheter surfaces. Particular problems arise from colonisation with 
urease-producing species such as Proteus mirabilis, which form unusual crystalline biofilms 
that encrust catheter surfaces and block urine flow. Encrustation and blockage often lead to 
a range of serious clinical complications and emergency hospital referrals in long-term 
catheterised patients. Here we review current understanding of bacterial biofilm formation on 
urethral catheters, with a focus on crystalline biofilm formation by P. mirabilis, as well as 
approaches that may be used to control biofilm formation on these devices. 
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Introduction 
Urethral catheters have been used in human medicine for over 3500 years. The term 
catheter derives from the ancient Greek kathiénai, which can be translated as “to thrust into” 
or “to send down”, and describes a medical device used to drain fluid from a body cavity 
(Mattelaer and Billiet 1995; Feneley et al. 2015). The Foley catheter, widely used in medical 
practice today, first became commercially available in the late 1930s, and the basic design 
of these devices remains largely unchanged in modern versions (Foley 1937; Feneley et al. 
2015). These devices are most commonly made from latex or silicone, and consist of a 
flexible tube inserted through the urethra into the bladder, where it is held in place by a 
retention balloon inflated with a saline solution. There are two channels running through the 
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tube; one to allow the inflation of the retention balloon, and the other to allow the drainage of 
urine from the bladder via an eye-hole in the catheter tip (Figure 1).  
 
These devices are deployed to treat numerous conditions related to bladder dysfunction and 
management of urine output, with duration of catheterisation ranging from short-term usage 
(up to ~7 days) in clinical settings such as hospitals, to long-term use (28 days and longer) in 
patients cared for in the community or in nursing home settings (Stickler 2008; Loveday et 
al. 2014; Stickler 2014; Shackley et al. 2017). The latter includes the use of long-term 
urethral catheterisation to manage urinary incontinence in elderly individuals and those with 
spinal cord injuries, as well as to minimise pressure ulcers and skin breakdown in immobile 
patients (Stickler 2008; Stickler 2014; Feneley et al. 2015).  
 
Urinary catheters are now the most commonly used medical devices worldwide, with 
estimates of over 100 million urethral catheters sold annually (Saint et al., 2000), and over 
30 million urinary catheters fitted every year in the USA alone (Darouiche 2001). Although 
these simple devices can provide considerable benefit to many individuals, their use 
undermines natural defences of the urinary tract (see below). Thus management of 
catheterised patients is frequently complicated by infection where formation of biofilms is a 
key feature (Kunin et al. 1997; Warren 2001; Stickler 2008; Stickler 2014). Given the prolific 
use of urinary catheters in modern medicine, it is therefore unsurprising that catheter-
associated urinary tract infections (CAUTI) are among the most common nosocomial 
infections (Loveday et al. 2014; Feneley et al. 2015). The prevalence of CAUTI is also 
associated with a significant financial and human cost, estimated to be £1.0-2.5 billion and 
up to 2100 deaths per year within the UK’s National Health Service (NHS) (Feneley et al. 
2015). 
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Catheter-associated urinary tract infection  
The introduction of a catheter circumvents innate barriers to microbial colonisation in the 
urinary tract, such as the continual sloughing of urethral epithelial cells and innate mucosal 
immune function, as well as the periodic flushing action of urine expelled from the bladder 
which efficiently prevents attachment and rebuffs invading microbes (Warren 2001; 
Jacobsen et al. 2008; Stickler 2014; Feneley et al. 2015). In contrast, urethral catheterisation 
presents bacteria with a readily-colonisable abiotic surface and promotes a slow continuous 
flow of urine from the bladder, effectively providing a “bridge” between the nutrient rich 
bladder and external environment (Warren 1991; Warren 2001; Stickler 2014). 
 
Bacteria may migrate from the skin surrounding the urethral opening into the urinary tract, 
using the external surfaces of the catheter, or in some cases may be introduced directly into 
the bladder on the catheter itself, if aseptic handling practices are not observed when fitting 
catheters (Warren 2001; Nicolle 2005; Stickler 2014). If the closed drainage system of the 
catheter is breached (for example during emptying or changing of drainage bags), bacteria 
can contaminate the system and ascend intra-luminally through the catheter into the bladder 
(Warren 2001; Nicolle 2005; Stickler 2014). Additionally, the design of the catheter and 
placement of the inflation balloon results in the formation of a residual pool of urine in the 
bladder, which is continually replenished with fresh nutrients from the kidneys (Warren 2001; 
Nicolle 2005; Stickler 2014). This creates an ideal environment for dense bacterial growth, 
and, once organisms have taken advantage of the catheter to reach this location, they are 
provided with ideal conditions in which to flourish.  
 
Although the majority of catheters deployed in the NHS will be used for short-term 
catheterisation in hospitalised patients, a notable proportion will be used for long-term 
indwelling catheterisation of patients in community care or nursing home settings (Royal 
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College of Physicians 2010; Prinjha and Chapple 2013; Shackley et al. 2017). A recent 
prospective study of urinary catheter use in over 9 million NHS patients indicated that 
around 22.2% of catheterised patients undergo long-term indwelling catheterisation 
(equating to >256,000 patients over the ~4 year study period), with the majority of these 
patients cared for in the community (>180,000 patients) (Shackley et al. 2017). Furthermore, 
national audits suggest that for patients aged over 65, ~7% cared for in the community and 
~10% of nursing home residents may be living with permanent urethral catheterisation 
(Royal College of Physicians 2010).  
 
Since the risk of CAUTI increases with duration of catheterisation, and patients in community 
care are usually not subject to the continuous clinical monitoring intrinsic to hospital care, 
this group of individuals are not only at high risk of infection but also more likely to be 
harmed by the complications that can arise as a consequence of CAUTI and associated 
biofilm formation (Kohler-Ockmore and Fenely 1996; Stickler 2014). Congruent with this are 
estimates suggesting the cost of treating CAUTI and associated complications in long-term 
catheterised patients in the community may be as high as £10,000 per patient, along with 
studies highlighting the prevalence of emergency hospital referrals in this group (Kohler-
Ockmore and  Fenely 1996; Evans et al. 2000). The use of these devices and the size of the 
global urinary catheter market is predicted to continue to grow, along with the complications 
associated with the use of current catheter designs and the formation of bacterial biofilms on 
these devices (Prinjha and Chapple 2013; Feneley et al. 2015). 
 
Biofilm formation and catheter encrustation 
A biofilm can be defined as a surface-associated microbial community comprised of cells 
embedded within a matrix of extracellular polymeric substances (EPS) (Donlan 2002; 
Donlan and Costerton 2002; Fux et al. 2005). The majority of bacterial cells in nature are 
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believed to exist in biofilm communities, which provides benefits in dealing with 
environmental stresses and confers a survival advantage over growth in the planktonic state 
(Donlan 2002; Donlan and Costerton 2002; Fux et al. 2005). Biofilm-associated cells exhibit 
reduced growth rates, distinct physiological characteristics, and altered gene expression 
compared to their planktonic counterparts (Donlan and Costerton 2002; Hall-Stoodley et al. 
2004; Fux et al. 2005). The EPS surrounding the community also protects cells from harmful 
agents, by acting as a diffusion barrier or neutralizing or binding the agent, as well as 
providing mechanical support and resistance to shear stresses generated by flow of the 
surrounding milieu (Donlan and Costerton 2002; Fux et al. 2005; Flemming et al. 2007). 
These characteristics mean that biofilms which develop in clinical settings and on implanted 
medical devices often present a particular challenge in terms of infection control and 
treatment (Donlan 2001). The structure and physiological characteristics of biofilms confer 
protection from normal immune clearance and resistance to antimicrobials, even if 
constituent microbes are fully susceptible in planktonic culture (Donlan 2001; Hall-Stoodley 
et al. 2004; Fux et al. 2005; Touzel et al. 2016). 
 
Biofilms form readily on urinary catheters, aided by the characteristics and topology of the 
catheter surface, the formation of conditioning layers, and the constant supply of nutrients 
from urine flowing through them (Stickler et al. 1993; Stickler et al. 1998; Downer et al. 2003; 
Stickler 2008). In particular, it has been demonstrated that irregularities and surface 
striations around the catheter eye-hole derived from the manufacturing process facilitate the 
initial adhesion of bacterial cells to the catheter (Stickler et al. 2003; Stickler 2008). Latex 
catheters may also contain embedded diatom skeletons that act as sites for bacterial 
attachment, and result from the use of diatomaceous earth in the injection moulding process 
(Stickler et al. 2003; Stickler 2008; Stickler and Morgan 2008).  
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Following the insertion of a urinary catheter, a conditioning film derived from constituents of 
the urine and host proteins such as fibrinogen can form on the catheter surface, which also 
supports bacterial adhesion and the initiation of biofilm formation (Donlan and Costerton 
2002; Stickler 2008; Stickler and Morgan 2008). Because patients catheterised for a period 
of 4 weeks or more are almost certain to become bacteriuric, catheters in many individuals 
undergoing long-term catheterisation will be exposed to contaminated urine for a 
considerable period of time. This also means that newly inserted catheters may be quickly 
colonised and biofilms rapidly established (Warren 2001; Stickler 2008; Stickler 2014).  
 
While Escherichia coli remains the most commonly isolated bacterial pathogen in 
uncomplicated UTI, a broader range of species are prevalent in CAUTI including Proteus 
mirabilis, Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa, 
Morganella morganii, Providencia sp. and Klebsiella pneumoniae (Warren 2001; Macleod 
and Stickler 2007; Stickler 2008). P. mirabilis, Ps. aeruginosa, E. coli, and E. faecalis are the 
most commonly isolated pathogens, and either single species or polymicrobial biofilms may 
form on catheters, although in patients with long-term catheters, polymicrobial communities 
are more likely (Warren 2001; Macleod and Stickler 2007; Stickler 2008).  
 
As modelling mixed species biofilms is more challenging than single species biofilms, there 
are fewer studies focused on polymicrobial CAUTI and biofilm formation, and further 
research is required in this area (Norsworthy and Pearson 2017). However, studies utilising 
a representative in vitro model of the catheterised urinary tract have proven useful in 
studying the formation of mixed species biofilms on urinary catheters (Stickler et al. 1999; 
Macleod and Stickler 2007). Importantly, these studies have highlighted the potential for 
antagonistic interactions between species that commonly infect the catheterised urinary tract 
(Macleod and Stickler 2007). Of note was the apparent exclusion of the particularly 
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problematic CAUTI pathogen P. mirabilis, which causes catheter encrustation and blockage 
through formation of unusual crystalline biofilms, by species such as Enterobacteria cloacae 
and Ps. aeruginosa (Macleod and Stickler 2007).  
 
Crystalline biofilm formation is the cause of many of the most important and common clinical 
complications that are associated with long-term urethral catheterisation (Kohler-Ockmore 
and Feneley 1996; Kunin et al. 1997; Jacobsen et al. 2008; Stickler 2008; Stickler 2014; 
Feneley et al. 2015). This is compounded by the potential for encrustation and blockage to 
occur rapidly without warning, and the majority of long-term catheterised patients being 
managed in community care settings (Kohler-Ockmore and Feneley 1996; Stickler et al. 
2006a; Long et al. 2014; Stickler 2014). Together, these factors mean blockage is often not 
noticed until more serious complications develop (Kohler-Ockmore and Feneley 1996; 
Sticker et al. 2006a; Long et al. 2014; Stickler 2014).  
 
Catheter blockage can result in urine leakage causing incontinence, but often leads to 
accumulation of infected urine in the bladder, and eventual reflux of infected urine to the 
upper urinary tract and kidneys. Reflux of infected urine can subsequently initiate serious 
sequelae such as pyelonephritis, septicaemia, and shock (Warren 2001; Jacobsen et al. 
2008; Stickler 2014; Feneley et al. 2015). Additionally, because the crystalline deposits are 
hard and abrasive, encrustations that form on the catheter tip and balloon can cause trauma 
to the bladder mucosa and urethra on catheter removal (Stickler 2008). Deflation of the 
catheter balloon can lead to fragmentation of encrustations which remain in the bladder 
where they further damage and irritate the bladder mucosa, and act as foci for the formation 
of bladder stones and reinfection of the catheterised urinary tract (Stickler 2008; Feneley et 
al. 2015). The crystalline nature of these biofilms also further contributes to the recalcitrance 
of these communities to antibiotics, with mineralisation of the biofilm shown to provide 
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greater protection of bacterial cells from antimicrobials compared to non-crystalline biofilms 
(Li et al. 2016).  
 
It has been suggested that ~50% of patients undergoing long-term catheterisation will 
experience catheter blockage, and in many cases this will become a recurrent long-term 
problem (Kohler-Ockmore and Feneley 1996; Kunin et al. 1997; Mathur et al. 2005). It is 
therefore unsurprising that catheter blockage results in many emergency referrals which 
place a strain on healthcare systems. The scale of this problem was highlighted by Kohler-
Ockmore and Feneley (1996) who recorded 506 emergency referrals from a group of 457 
long-term catheterised patients over a 6 month period, mainly as a result of catheter 
blockage (Kohler-Ockmore and Feneley 1996).  
 
Proteus mirabilis and crystalline biofilm formation 
The formation of crystalline biofilms is the result of infection with urease producing bacterial 
species including Providencia rettgeri, P. vulgaris, and P. mirabilis, with the latter being the 
main cause of catheter encrustation and blockage (Stickler et al. 1993; Stickler et al. 1998, 
Macleod and Stickler 2007; Broomfield et al. 2009). P. mirabilis is not usually an early 
coloniser of the catheterised urinary tract, but with increasing duration of catheterisation the 
likelihood of P. mirabilis colonisation increases, and this species can be isolated from up to 
40% of long-term catheterised patients experiencing catheter encrustation and blockage 
(Macleod and Stickler 2007). The combination of a strong ability to form biofilms on catheter 
surfaces and production of a highly active urease are the key factors driving the encrustation 
of catheters by this species (Figure 2).  
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The ureolytic activity of P. mirabilis in the catheterised urinary tract leads to the generation of 
ammonia, and the elevation of urinary pH (Griffith et al. 1976; Jones and Mobley 1987; 
Stickler et al. 1993;). Under these alkaline conditions normally soluble constituents of the 
urine precipitate and begin to form crystals of magnesium ammonium phosphate (struvite) 
and calcium phosphate (hydroxyapatite) (Griffith et al. 1976; Hedelin et al. 1984; Cox and 
Hukins 1989; Stickler et al. 1993; Holling et al. 2014a). These crystals become trapped 
within the developing biofilms where their growth is stabilised and enhanced by the biofilm 
matrix, ultimately resulting in the formation of a mineralised biofilm structure (Stickler et al. 
1993; Dumanski 1994; Stickler 2014; Figure 2). P. mirabilis urease has been shown to 
hydrolyse urea at a much greater rate and block catheters more rapidly than other urease 
producing bacteria associated with CAUTI (Jones and Mobley 1987; Broomfield et al. 2009). 
P. mirabilis catheter biofilms may also constitute highly alkaline microenvironments in 
otherwise acid or neutral urine, which could potentially facilitate localised crystallisation 
within the biofilm even when pH of the bulk urine is not optimal for crystal formation (Stickler 
et al. 1993a).  
 
Using episcopic differential interference contrast (EDIC) microscopy, Wilks et al. (2015) have 
proposed that P. mirabilis crystalline biofilms form in four consecutive stages. These include 
the initial development of a foundation layer where small numbers of cells are initially 
supported by relatively large amounts of extracellular polysaccharide, followed by formation 
of a microcrystalline layer overlying this, before accumulation of larger amounts of crystalline 
material, and finally continued expansion of the biofilm to form the mature crystalline biofilm 
structure (Wilks et al. 2015). In contrast, other studies have indicated initial stages include 
the formation of a microcrystalline conditioning layer to which cells preferentially attach 
(Stickler and Morgan 2008).  
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Observations using Environmental Scanning Electron Microscopy (ESEM) of crystalline 
biofilms also provided further insight into the structure of these communities (Holling et al. 
2014a). An important feature of ESEM is the capacity to image fully hydrated samples 
without the normal dehydration and fixation required for viewing samples by standard SEM. 
ESEM may also be coupled with techniques such as energy dispersive X-ray analysis (EDS) 
to investigate the chemical composition of structures observed (Bergmans et al. 2005; 
Hannig et al. 2010; Holling et al. 2014a). Application of ESEM and EDS to P. mirabilis 
crystalline biofilms has revealed the presence of delicate sheet-like crystalline structures of 
calcium phosphates, possibly derived from turnover of microcrystalline conditioning layers 
that form on catheter surfaces, as well as the extensive calcification of the biofilm matrix as a 
whole (Holling et al. 2014a). 
 
Bladder stones that form in the residual pool of urine in the bladder are also common in 
long-term catheterised patients (Feneley et al. 2002; Sabbuba et al. 2004). These are also 
predominantly associated with P. mirabilis infection and believed to arise through an 
analogous process to crystalline biofilm formation (Bichler et al. 2002; Feneley et al. 2002; 
Sabbuba et al. 2004; Schaffer et al. 2016). The composition of bladder stones and 
crystalline biofilms is comparable, and the same strain of P. mirabilis may be found within 
the biofilm and bladder stones in a particular patient (Bichler et al. 2002; Sabbuba et al. 
2004). P. mirabilis cells growing in the residual bladder urine or invading the bladder mucosa 
can act as foci for de novo stone formation, and viable cells have been found within these 
structures (Bichler et al. 2002; Sabbuba et al. 2004; Schaffer et al. 2016). Alternatively, 
encrustations that form on the exterior surfaces of the catheter and balloon while the 
catheter is in place, detach when the balloon is deflated during catheter removal, and initiate 
stone formation (Stickler 2008). The fact that P. mirabilis cells remain viable in stones is 
likely an important factor in the ability of this species to cause chronic infection and recurrent 
catheter blockage, with stones providing protection from mechanical, immune, and 
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antimicrobial clearing, as well as acting as reservoirs for reinfection following treatment or 
catheter changes (Sabbuba et al. 2004; Stickler 2014).  
 
Mechanisms underlying P. mirabilis crystalline biofilm formation and virulence 
In addition to urease production, P. mirabilis exhibits a number of other attributes and 
virulence factors that may be involved in crystalline biofilm formation and the pathogenesis 
of CAUTI. A particularly striking feature of P. mirabilis is its swarming motility, in which 
elongated, hyperflagellated swarmer cells form multicellular rafts and move rapidly over solid 
surfaces (Jones et al. 2004; Rather 2005; Morgenstein et al. 2010; Figure 3). This cyclic 
behaviour is responsible for the characteristic “bulls-eye” or terraced appearance of P. 
mirabilis colonies grown on agar plates, with each terrace representing one swarm cycle 
(Figure 3). Although swarming cells in P. mirabilis do not fully fit conventional definitions of a 
biofilm due to the motility of swarmer cell rafts, this highly coordinated multicellular behaviour 
shares many features with biofilm-associated cells. This includes altered gene expression, 
cell physiology, extracellular polysaccharide matrix production, and altered susceptibility to 
antimicrobials (Gygi et al. 1995; Jones et al. 2004; Rather 2005; Morgenstein et al. 2010). 
 
Since P. mirabilis is capable of swarming over different types of catheter surfaces this 
motility has been implicated in its ability to migrate from the periurethral skin, along the 
catheter and into the bladder initiating CAUTI (Stickler and Hughes 1999; Sabbuba et al. 
2002; Jones et al. 2004). Swarmer cells also exhibit an increased expression of virulence 
factors including urease, and it has been hypothesised that in conjunction with swarming 
motility this may facilitate expansion and spreading of crystalline biofilms across catheter 
surfaces (Stickler and Hughes 1999; Fraser et al. 2002; Sabbuba et al. 2002). Observations 
of P. mirabilis biofilms grown on catheters have also indicated the presence of swarmer cells 
within established biofilms (Stickler and Morgan 2006). 
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However, the role of swarming in pathogenesis of CAUTI and crystalline biofilm formation 
remains largely enigmatic. Neither swimming or swarming motilities have been found to be 
essential for crystalline biofilm formation and catheter blockage, with non-swarming mutants 
reported to have greater biofilm forming ability in some studies (Jones et al. 2005; Holling et 
al. 2104b). These observations also fit with transcriptomic analyses which have revealed a 
coordinated regulation of motile and adherent states in P. mirabilis, whereby flagellar 
biosynthesis and motility are repressed in response to signals that upregulate fimbrial 
production (Pearson and Mobley 2008; Pearson et al. 2010). Overall, present evidence 
suggests swarming may play a role in initial colonisation of the catheterised urinary tract, but 
that this motility is not essential for subsequent crystalline biofilm formation. However, there 
remains potential for differentiated swarmer cells to play a structural role in development of 
crystalline biofilms, unrelated to surface-associated motility. 
 
The complete genome sequence of P. mirabilis has also shed light on mechanisms 
underlying the strong biofilm forming ability exhibited by P. mirabilis (Pearson et al. 2008b). 
Of particular relevance to biofilm formation are the large number of fimbrial operons encoded 
by P. mirabilis, affording the potential for generation of up to 17 distinct fimbrial structures in 
this species (Pearson et al. 2008b). Several P. mirabilis fimbria are already known to 
facilitate attachment to host cells and tissues as well as some catheter biomaterials, with 
conditioning layers that form on catheters thought to provide additional receptors for fimbriae 
and other adhesins (Bahrani, et al. 1994; Massad et al. 1994; Zunino et al. 2003; Jansen et 
al. 2004; Himpsl et al. 2008; Jacobsen et al. 2008; Stickler 2008; Pearson et al. 2008; 
Armbruster and Mobley 2012; Pellegrino et al. 2013; Scavone et al. 2016). However, 
although fimbriae-mediating host cell attachment have been shown to play a critical role in 
the pathogenesis of ascending UTI, further work is required to clearly elucidate which fimbria 
may be key to crystalline biofilm formation, and the role of many fimbria that may be 
produced by P. mirabilis remain unknown (Bahrani et al. 1994; Massad et al. 1994; Zunino 
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et al. 2003; Jansen et al. 2004; Himpsl et al. 2008; Pellegrino et al. 2013; Scavone et al. 
2016).  
 
Other functions related to crystalline biofilm formation specifically have been identified 
through construction and screening of mutants altered in ability to form biofilms. Holling et al. 
(2014b) used a random transposon mutagenesis approach to identify genes important to P. 
mirabilis biofilm formation and catheter blockage, which indicated an unexpected role for 
genes encoding efflux systems. Mutants disrupted in the putative multidrug bcr/CflA efflux 
pump were attenuated in ability to form crystalline biofilms and block catheters in an in vitro 
model of the catheterised urinary tract (Holling et al. 2014b). The role of efflux in biofilm 
formation in other pathogens has also been reported, with increased expression of efflux 
pumps noted in biofilm-associated cells compared to planktonic cells, the chemical inhibition 
or deletion of relevant genes resulting in attenuation or abolition of biofilm formation, and 
efflux linked with the increased antibiotic resistance of biofilms. (Kvist et al. 2008; Zhang and 
Mah 2008; Matsumara et al. 2011; Soto et al. 2013; Baugh et al. 2014; Holling et al. 2014b; 
Nzakizwanayo et al. 2017). Importantly, such studies also serve to highlight potential new 
targets for biofilm control, with subsequent investigations demonstrating that inhibitors of 
efflux in P. mirabilis can also reduce crystalline biofilm formation (Nzakizwanayo et al. 2017). 
 
Although roles of motility, fimbria production, and efflux, have been studied in P. mirabilis 
biofilm formation, other mechanisms of multicellular coordination and biofilm formation well 
described in other pathogens are yet to be clearly elucidated in P. mirabilis. Key among 
these are quorum sensing (QS) systems that regulate population density dependant gene 
expression in a wide range of bacterial species, and contribute to the coordination of biofilm 
formation in other uropathogens such as Ps. aeruginosa (Chugani et al. 2001; Ng and 
Bassler 2009; Antunes et al. 2010). Although multicellular behaviours exhibited by P. 
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mirabilis (biofilm formation and swarming) are likely to involve considerable cell-cell 
communication, P. mirabilis lacks clearly identifiable homologues of the canonical LuxI 
synthase, and does not generate Acyl-homoserine lactones (AHL) utilised as QS signal 
molecules in other Gram negative species (Belas et al. 1998; Pearson et al. 2008). An intact 
AI-2 QS circuit (often involved in both inter and intra-species QS signalling) is also 
seemingly absent in P. mirabilis, and while production of the AI-2 signal molecule and a 
homologue to the AI-2 senor luxS has been identified, inactivation of luxS appears to have 
no significant impact on virulence and swarming (Schneider et al. 2002).  
 
However, P. mirabilis appears to be able to still respond to exogenous AHLs generated by 
other species, which is reported to influence biofilm formation (Stanskowska et al. 2012). 
This has led to the hypothesis that P. mirabilis is able to modulate behaviours related to 
virulence in response to AHL production by other pathogens during polymicrobial infection 
(Armbruster and Mobley 2012).  A range of other molecules have also been suggested to be 
detected and used by P. mirabilis to regulate virulence related gene expression in a QS-like 
fashion, including fatty acids, and putrescine, as well as diketopiperazines which may 
function as an alternative AHL-like signal molecule in P. mirabilis (Holden et al. 1999; Liaw 
et al. 2004; Sturgill and Rather 2004). However, the importance and role of these potential 
signalling molecules, and QS in general, to P. mirabilis biofilm formation and CAUTI remain 
unknown.  
 
Approaches to control crystalline biofilm formation and catheter blockage 
A wide range of strategies have been developed and evaluated in order to control CAUTI, 
and in particular the formation of crystalline biofilms and associated blockage of catheters. 
These range from those focused on the modification of catheter surfaces to prevent 
microbial adhesion or impart antimicrobial activities, to approaches seeking to offset the 
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formation of crystals through dietary modulation of urinary pH, and studies on behavioural 
interventions to catheter management in different healthcare settings (Jones et al. 2018). 
More recently, approaches based on new understanding of the molecular genetic basis of P. 
mirabilis crystalline biofilm formation, alternatives to conventional antimicrobial agents, and 
the use of early warning systems to signal the possibility of catheter blockage have been 
described (Stickler et al. 2003; Holling et al. 2014b; Nzakizwanayo et al. 2016; Milo et al. 
2016; Milo et al. 2017; Nzakizwanayo et al. 2017; Milo et al. 2018).   
 
Dietary intervention. 
Dietary intervention represents a potentially simple, economical, widely applicable, and safe 
intervention, and several approaches have been evaluated for the control of encrustation 
specifically. In particular, the consumption of cranberry juice (or compounds derived from 
cranberry) has long been proposed to hold therapeutic or prophylactic potential in the control 
of uncomplicated UTI, and suggested to inhibit growth and adherence of uropathogens in 
the urinary tract (Bodel et al. 1959; Ofek et al. 1991; Avorn et al. 1994; Kuminski 1996; 
McMurdo et al. 2005; Thomas et al. 2017).  
 
However, studies in which urine from volunteers consuming 1 L of cranberry juice per day 
was collected and used in in vitro models of P. mirabilis catheter infection, showed no 
significant impact on the production of crystalline biofilms and catheter blockage from 
consumption of cranberry juice specifically (Morris and Stickler 2001).  Nevertheless, 
volunteers who consumed either cranberry juice or water as a control did generate urine that 
resulted in slower rates of biofilm formation in models, compared to urine from volunteers 
who had not consumed any additional fluids. Collectively these observations indicated 
increased fluid intake in general, but not cranberry juice specifically, is effective in reducing 
the rate of crystalline biofilm formation and prolonging catheter lifespan (Morris and Stickler 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
2001). Conversely, small scale clinical studies of concentrated proanthocyanins, extracted 
from cranberry, have indicated daily consumption in capsules could reduce the incidence of 
symptomatic CAUTI (Thomas et al. 2017). Although blockage specifically was not examined 
in this study, and it is not clear if this will also be effective in controlling encrustation.  
 
The effects of increased intake of fluid on reducing encrustation rates are also in keeping 
with clinical observations relating to the variation in the threshold pH at which encrustation 
occurs in catheterised patients. This is termed the nucleation pH (pHn) and is the pH at 
which calcium and magnesium phosphates begin to precipitate from urine and crystal 
formation is initiated (Choong et al. 1999; Choong et al. 2001). Previous studies have 
indicated that catheterised individuals exhibiting recurrent blockage have significantly 
reduced pHn values compared to patients who were not exhibiting catheter blockage 
(Choong et al. 1999; Choong et al. 2001; Mathur et al. 2005). However, the pHn of urine 
varies both within a patient over time and between individuals, and it is possible to 
manipulate this factor in order to reduce the risk of encrustation and blockage through 
increased fluid intake (Choong et al. 1999; Choong et al. 2001; Suller et al. 2005; Mathur et 
al. 2005; Broomfield et al. 2009; Stickler and Morgan 2006).  
 
Alternatively increasing the intake of dietary components that influence urinary pH may also 
be effective in reducing encrustation, and both clinical and laboratory studies have shown 
potential to do this through increased consumption of citrated drinks (Broomfield et al. 2009; 
Kahn et al. 2010). Notably, the intake of 1 L of citrate drink among catheterised patients 
significantly increased their average urinary pHn reducing the risk of catheter encrustation 
(Khan et al. 2010). However, while it is clear that increased fluid intake and consumption of 
citrated beverages is likely to be beneficial for catheterised patients, maintaining these kinds 
of dietary modifications over prolonged periods can be a challenge for many patients. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Surface modifications and antimicrobial catheters.  
The formation of conditioning films and initial attachment of bacteria to catheter surfaces 
represents the first stages of biofilm formation, and preventing these events should provide 
effective control of catheter-associated biofilm formation. Strategies to inhibit these early 
stages of catheter colonisation involve modifying surface properties of catheters such as 
hydrophobicity, charge, and topology, or to incorporate antimicrobial agents intended to kill 
colonising microbes.  
 
Catheters and other devices with hydrophilic surface coatings have been commercially 
available for some time, and intended to not only increase comfort of catheterised patients, 
but also to make these surfaces less vulnerable to the development of conditioning layers, 
and less attractive for bacterial colonisation (Donlan 2001; Stensballe et al. 2005). Examples 
of catheters in which hydrogel coatings have been augmented by incorporation of 
antimicrobial agents such as silver, or where catheter biomaterials have been directly 
impregnated with antimicrobial agents are also widely available (Morris et al. 1997; Maki et 
al. 2001; Pickard et al. 2012). Despite claims from some manufacturers that such devices 
are effective in preventing catheter encrustation, current evidence suggest these general 
strategies perform poorly in the control of P. mirabilis crystalline biofilm formation (Morris et 
al. 1997; Stickler and Morgan 2008; Desai et al. 2010; Pickard et al. 2012).   
 
Studies evaluating the recalcitrance of numerous catheter types to crystalline biofilm 
formation, using in vitro models of the catheterised urinary tract, have demonstrated that all 
catheter types tested remained vulnerable to encrustation by P. mirabilis (Morris et al. 1997; 
Stickler et al. 2002; Stickler and Morgan 2008). These studies included those with hydrogel 
coatings, phosphorylcholine coatings, as well as silver containing hydrogels, or catheters 
impregnated with antibiotics such as nitrofurazone (Morris et al. 1997; Stickler et al. 2002; 
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Stickler and Morgan 2008). These laboratory studies are also supported by clinical 
observations, with recent large scale clinical trials of silver-alloy and nitrofurazone coated 
catheters demonstrating no significant impact on incidence of CAUTI in catheterised patients 
(Pickard et al. 2012). Although this trial focused on short-term catheterised patients in a 
hospital setting, it is most likely that such catheters would be even less effective in the 
control of colonisation in long-term catheterised individuals, where they must function 
effectively to exclude microbes for weeks or months at a time. This is congruent with direct 
observations of crystalline biofilm formation on hydrogel/silver coated catheters removed 
from patients, and the rapid formation of P. mirabilis induced encrustations on 
hydrogel/silver coated and nitrofurazone silicone catheters in laboratory models (Stickler and 
Morgan 2008). 
 
In the case of antimicrobial agents, P. mirabilis is intrinsically resistant to a range of 
antibiotics and biocides, including nitrofurazone, and the continual elution of agents from 
catheters may also rapidly reduce levels of agents to concentrations that are no longer 
effective (Johnson et al. 1993a; Stickler and Morgan 2008; Stickler 2014). This depletion of 
antimicrobials is also believed to contribute to the development and selection of antimicrobial 
resistance (Stickler 2014; Feneley et al. 2015). Furthermore, the formation of 
microcrystalline conditioning layers may provide suitable attachment sites for cells whilst 
shielding them from antimicrobial agents, undermining the ability of hydrogel coatings and 
antimicrobial coatings to resist biofilm formation (Stickler and Morgan 2008). In the case of 
catheters containing antimicrobials, pioneering cells killed and attached to the surface may 
also contribute to the eventual failure of this control method, acting as foci for further 
attachment whilst providing protection to cells that adhere later. Nevertheless, incorporation 
of antimicrobial agents into catheters continues to be an area of active development. New 
approaches to incorporate antimicrobials into catheter biomaterials, along with the use of a 
combination of antimicrobial agents, have the potential to increase both longevity and 
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efficacy of these devices against challenging pathogens such as P. mirabilis (Fisher at al. 
2015). 
 
More recently, surface modification approaches based on generation of defined nanoscale 
surface patterns that are inhibitory to microbial growth and attachment have been described, 
and suggested to be of use in the control of catheter biofilms (Schumacher et al. 2008; 
Reddy et al. 2011; Mann et al. 2014; Vasudevan et al. 2014). For example the Sharklet™ 
micropatterned surface has been shown to inhibit the ability of uropathogenic E. coli and S. 
aureus to colonise and form biofilms in in vitro laboratory studies (Reddy et al. 2011; Mann 
et al. 2014). The nanoscale structures forming the topologies in surfaces such as the 
Sharklet™ are proposed to work by generating mechanical stress on colonising cells, forcing 
them to continually adjust contact angle relative to the surface structures, ultimately 
inhibiting attachment (Schumacher et al. 2008). However, it is currently unclear how well 
such surfaces will perform when tested against P. mirabilis, and under highly challenging 
conditions which promote crystalline biofilm formation. It would seem possible that formation 
of crystalline conditioning layers and encrustation by P. mirabilis could also overcome this 
approach as with other surface modification strategies. 
 
Triclosan and Farco-fill. 
The broad spectrum biocide triclosan has been widely used in numerous applications 
ranging from incorporation in many domestic products and surfaces, to use in dental hygiene 
products and surgical scrubs (Sticker et al. 2003). P. mirabilis has exquisite sensitivity to 
triclosan, and this agent has been shown to be effective in the control of crystalline biofilm 
formation and catheter blockage using in vitro bladder models inoculated with P. mirabilis 
alone, or in polymicrobial communities (Sticker et al. 2003; Jones et al. 2006; Stickler and 
Morgan 2008; Williams et al. 2008). Importantly, this agent may be effectively delivered to 
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the catheterised urinary tract over a sustained period of time by using concentrated solutions 
of triclosan to fill retention balloons of all silicone catheters (Stickler et al. 2003). Triclosan is 
able to easily diffuse through the silicone catheter material, into the surrounding urine and 
provide effective control of P. mirabilis and crystalline biofilm formation (Stickler et al. 2003).  
 
The success of this approach has ultimately led to the development of a fully licensed 
product (Farco-fill®), available to patients on prescription. Although this approach 
undoubtedly benefits many individuals and has had considerable positive impact, clinical 
evaluation indicated the Farco-fill® inflation solution was only able to reduce encrustation in 
34.5% of patients tested (Pannek and Vestweber 2011), though further clinical evaluation is 
required to fully understand the clinical efficacy of this product. A further possible issue with 
this approach is the potential for the emergence of resistant P. mirabilis strains, which have 
already been described in laboratory studies of P. mirabilis triclosan resistance (Stickler and 
Jones 2008). The mutants generated in these studies included those with high level triclosan 
resistance unaffected by inflation of retention balloons with triclosan solutions (Stickler and 
Jones 2008). 
 
Urease inhibitors. 
Owing to its critical role in the development of crystalline biofilms, the urease enzyme is a 
key target for control of catheter encrustation. Mutants of P. mirabilis lacking urease activity 
have been shown to be unable to form crystalline biofilms and block catheters, and a role for 
this enzyme in other aspects of P. mirabilis pathogenesis as also been described, including 
persistence in the upper urinary tract and renal damage during pyelonephritis (Jones et al. 
1990; Johnson et al. 1993b; Dattelbaum 2003; Schaffer et al. 2016). Although numerous 
potential urease inhibitors have been identified from a wide range of sources, many have 
failed to progress beyond laboratory studies due to issues of toxicity or stability, and few 
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compounds are available for clinical use (Hassan and Šudomová 2017; Kafarski and Talma 
2018). 
 
In terms of urinary tract infection and catheter encrustation, acetohydroxamic acid 
(Lithostat®) has been shown to have efficacy in the reduction of bladder stone formation, 
catheter encrustation, and the resolution of chronic infection by urease producers when used 
in synergy with antibiotics (Griffith et al. 1979; Burns and  Guthhier 1984; Griffith et al. 1988; 
Griffith et al. 1991). However, the use of this drug is undermined by a range of side effects 
and complications related to toxicity, and is often poorly tolerated by patients. Currently 
lithostat is only recommended for use when other treatments have failed and in specific 
groups of patients. Nevertheless, the clinical application of lithostat continues to benefit 
many individuals with chronic urinary tract infection by urease producers, and has confirmed 
the inhibition of urease as a viable approach to control catheter blockage. Further 
development of this approach may include the desgin of localised delivery systems that 
negate the need for systemic administration of drugs such as lithostat, which could avoid 
side effects and expand the range of patients who may benefit from these treatments. 
 
Early warning systems. 
The detection and signalling of events that indicate blockage of catheters may be imminent 
have also been explored as a strategy to help control catheter blockage, and reduce the 
complications associated with crystalline biofilm formation. The basic principle is to alert 
patients or carers that a catheter is at risk of blockage so intervention can be provided 
before complications arise. Early warning systems described so far have focused on the 
detection of pH changes in urine indicative of infection with P. mirabilis and other urease 
producers, and a key parameter in the formation of crystalline biofilms (Stickler et al. 2006a; 
Stickler et al. 2006b; Long et al. 2014; Milo et al. 2016; Zhou et al. 2018; Milo et al. 2018). 
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The first early warning system was described by Stickler et al. (Stickler et al. 2006b) and 
consists of a cellulose acetate matrix incorporating the pH indicator Bromothymol Blue, 
which changes from yellow to blue over the pH range 6-8 (Stickler et al. 2006b). These 
sensors were evaluated initially in in vitro bladder models, positioned either in the drainage 
bag or within tubing between the junction of the catheter and drainage bag connection, and 
provided up to 43 h advanced warning of blockage (Stickler et al. 2006b). Although highly 
promising in laboratory studies, clinical evaluation of this pH based chemical sensor 
approach has indicated that sensors may be activated weeks before blockage occurs, and 
identified considerable patient to patient variation in sensor performance (Stickler et al. 
2006a; Long et al. 2014). These studies suggest that while these pH sensor based early 
warning systems are potentially useful for many patients, improvements are required in the 
accuracy and consistency of blockage prediction, as well as a reduction in the duration 
between sensor activation and blockage.  
 
A variation on this approach has also recently reported by Milo and colleagues who 
developed pH responsive drainage bag sensors and coatings for catheters (Milo et al. 2016; 
Milo et al. 2018). These were based on incorporation of the dye carboxyfluorescein within a 
hydrogel matrix encapsulated by the pH responsive Eudragit polymer (Milo et al. 2016; Milo 
et al. 2018). In this system dissolution of the Eudragit polymer at elevated pH allows 
diffusion of the carboxyfluorescein indicator out of the hydrogel layer and into the urine, 
where it imparts a distinctive bright green coloration that signals the potential for blockage 
(Milo et al. 2016; Milo et al. 2018). In laboratory models this pH sensor technology provided 
12-14 h advance warning of blockage, raising the possibility that this may provide a more 
accurate prediction of blockage, with shorter times between sensor activation and blockage 
(Milo et al. 2016; Milo et al. 2018). Furthermore, the design of these sensors mean 
therapeutic agents may also be loaded into the hydrogel matrix to provide “theranostic” 
systems capable of providing both early warning and directly combatting infection when 
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release is triggered (Milo et al. 2017; Zhou et al. 2018). However, this technology has not yet 
been subject to clinical evaluation and so it is currently uncertain how well this sensor 
technology, or any theranostic derivative, will perform under real-world conditions.  
 
Bacteriophage. 
The potential for bacteriophage (or phage) to provide an effective means of biofilm control in 
the context of CAUTI have been explored by several groups, and encouraging results 
reported (Curtin and Donlan 2006; Carson et al. 2010; Fu et al. 2010; Lehman et al. 2015; 
Melo et al. 2016; Nzakizwanayo et al.  2016; Milo et al. 2017). The properties of these 
bacterial viruses are particularly relevant to the eradication of biofilms, and aside from their 
ability to infect and kill bacterial cells, phage often possess attributes such as polysaccharide 
depolymerases that enable them to penetrate the bacterial biofilm matrix and infect 
constituent cells (Sutherland et al. 2004; Lu and Collins 2007). This feature of phage has 
been shown to facilitate the disaggregation and dispersal of biofilms (Sutherland et al. 2004; 
Lu and Collins 2007). 
 
Most recently, bacteriophage therapy has been shown to reduce P. mirabilis crystalline 
biofilm formation on catheters, and to prevent catheter blockage (Nzakizwanayo et al. 2016; 
Milo et al. 2017). Using in vitro bladder models, Nzakizwanayo et al. (2016) showed that a 
single dose of phage significantly extended time to blockage under conditions simulating 
established infection with P. mirabilis. When the same dose of phage was applied to models 
simulating early-stage infections, the treatment eradicated the infection and catheters 
continued to drain freely without encrustation for a period of 8 days until experiments were 
terminated (Nzakizwanayo et al. 2016).  
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Further work has also demonstrated the potential to incorporate phage into infection 
responsive coatings triggered by urine pH elevation, providing the potential for automatic 
release of phage into the urinary tract to combat crystalline biofilm formation during the early 
stages of infection (Milo et al. 2017). More complex multispecies catheter biofilms have also 
been shown to be susceptible to phage therapy, with two-species biofilms of P. mirabilis and 
Ps. aeruginosa reduced by up to 99.9% in continuous flow models over a period of 48 hours 
using polyvalent phage cocktails (Lehman and Donlan 2015). The potential to formulate 
mixtures of phage capable of eradicating target organisms is also considered an advantage 
of this approach in terms of offsetting the development of resistance.  
 
However, despite a renewed interest in phage therapy in light of increasing levels of 
antibiotic resistance, and mounting evidence for the efficacy of these viruses in treatment of 
bacterial infection, the development of phage therapy products intended for clinical use 
remains challenging. Particular challenges arise from the often narrow and strain specific 
host range of phage (which complicates development of broadly applicable phage mixtures), 
as well as issues related to production of phage preparations of the quality required for 
medicinal use, their route of administration and delivery, and the lack of a clear regulatory 
framework for phage products (Pirnay et al. 2015).  
 
Efflux pump inhibitors. 
Recent studies highlighting the role of efflux systems in bacterial biofilm formation, including 
P. mirabilis crystalline biofilm formation and catheter blockage, have led to the evaluation of 
compounds that inhibit these molecular pumps (efflux pump inhibitors; EPIs) for control of 
catheter biofilms (Kvist et al. 2008; Amaral et al. 2010; Holling et al. 2014b; Nzakizwanayo et 
al. 2017). Of particular significance are findings that drugs already used in human medicine 
can function as EPIs and attenuate the formation P. mirabilis crystalline biofilm formation 
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(Nzakizwanayo et al. 2017). Drugs from classes including the selective serotonin reuptake 
inhibitors and phenothiazines were found to exhibit putative EPI activity, with fluoxetine and 
thioridazine subsequently shown to significantly reduce crystalline biofilm formation and 
delay catheter blockage in in vitro models (Nzakizwanayo et al. 2017; Figure 4). This not 
only points to efflux inhibition as a viable target for control of P. mirabilis crystalline biofilm 
formation, but also the potential to repurpose a range of already licensed drugs to control 
these infections. 
 
 
Summary 
Bacterial biofilms remain a major problem in the care of many patients and continue to 
undermine the successful treatment of many infections. Patients managed by long-term 
urethral catheterisation are particularly vulnerable to biofilm related infections, with 
crystalline biofilm formation frequently leading to serious clinical episodes, emergency 
hospital referrals, and chronic long-term complications. Despite the large numbers of 
patients who are affected, and the enormous financial and human cost of these infections, 
there remains a general lack of awareness regarding the scale and impact of this problem 
(Prinjha and Chapple 2013). As the population of older individuals in many countries 
continues to rise, so too will the population of individuals subject to long-term catheterisation, 
along with the incidence of morbidity and mortality arising from associated infections and 
complications like crystalline biofilm formation.  
 
Although notable progress has been made by dedicated researchers and healthcare 
practitioners in a number of areas (which has undoubtedly benefitted many patients), truly 
effective and widely applicable strategies to control biofilm related complications faced by 
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catheterised patients remain elusive. As Feneley and colleagues have recently pointed out 
(Feneley et al. 2015), finding a solution to this important clinical problem should be 
achievable, but will require an interdisciplinary effort from the scientific community, as well 
as greater engagement and support from research funders, regulators, and industry.  
 
Figure legends: 
 
Figure 1: The Foley catheter. A) Example shows a standard 14Ch Bard all silicone 
catheter with retention balloon inflated. B) Shows enlarged view of catheter tip and balloon 
region. C) Cross-section through catheter showing inflation line and main drainage lumen.  
 
Figure 2: Proteus mirabilis crystalline biofilms. Examples of P. mirabilis crystalline 
biofilms formed on standard all-silicone Foley catheters, in in vitro models of the catheterised 
urinary tract. A) Scanning Electron Microscope image of catheter lumen showing formation 
of crystalline biofilm. B) Environmental Scanning Electron Microscope (ESEM) image of 
longitudinal cross-section of catheter lumen showing crystalline biofilm. C,D) Higher 
magnification ESEM images of established crystalline biofilms showing embedded struvite 
crystals. Images were generated by Dr N Holling. Part A is reproduced from Holling et al. 
2014b, and part C is reproduced from Holling et al. 2014a. 
 
Figure 3: Swarming in Proteus mirabilis. A) P. mirabilis swarming over an agar plates, 
demonstrating terraced appearance due to successive swarm cycles B,C) Scanning 
Electron Microscopy images of P. mirabilis swarmer cells fixed in situ during swarming over 
agar (Jones et al. 2004). Images demonstrated alignment and organisation of cells, as well 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
as interweaving of flagella filaments into helical connections between adjacent cells in the 
swarm front. Part C is reproduced from Jones et al. 2014. 
 
 
Figure 4: Impact of repurposed drugs on crystalline biofilm formation (from 
Nzakizwanayo et al 2017). Images show impact of the repurposed efflux inhibitors 
thioridazine and fluoxetine on P. mirabilis crystalline biofilm formation in an in vitro bladder 
model. Models were run for 10h using standard 14 Ch all-silicone catheters. In treated 
models artificial urine media was supplemented with either thioridazine (400 µg/ml) or 
fluoxetine (128 µg/ml). Cross-sections of catheters directly below the eye-hole were imaged 
using scanning electron microscopy to visualise crystalline biofilm formation. Models run 
under these conditions until catheter blockage also showed models supplemented with 
either thioridazine or fluoxetine took significantly longer to block than untreated controls. 
Reproduced from Nzakizwanayo et al. 2017 (http://creativecommons.org/licenses/by/4.0/). 
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